AHA's comment on CMS's 2019 Advance Notice and draft Call Letter for 2019.
Letters
Throughout the year, the AHA comments on a vast number of proposed and interim final rules put forth by the federal regulatory agencies. In addition, AHA communicates with federal legislators to convey the hospital field's position on potential legislative changes that would impact patients and patient care. Below are the most recent letters from the AHA to these bodies.
Latest
On behalf of our nearly 5,000 member hospitals, health systems and other health care organizations, and our clinician partners – including more than 270,000 affiliated physicians, 2 million nurses
The undersigned groups respectfully request that the Drug Enforcement Administration (DEA)
adjust aggregate production quotas (APQ) for certain opioids in order to mitigate ongoing drug
shortages.
The American Hospital Association responds to the Senate Finance Committee’s request for policy recommendations to address the opioid epidemic.
AHA comments to the Office of the National Coordinator for Health Information on its draft Trusted Exchange Framework and Common Agreement as well as ONC’s draft U.S. Core Data for Interoperability document.
The American Hospital Association's comments to the Energy and Commerce Subcommittee on Oversight and Investigations for its hearing on "Examining the Impact of Health Care Consolidation."
The American Hospital Association commends Rep. Hultgren for introducing legislation to restore the tax exemption for advance refunding bonds that was repealed in the Tax Cuts and Jobs Act.
The AHA requests additional information and a delay in implementation of the Centers for Medicare & Medicaid Services’ Bundled Payments for Care Improvement Advanced Model (BPCI Advanced) announced on Jan. 9.
AHA comments to provide feedback on the work that the Centers for Medicare & Medicaid Services (CMS) and the Assistant Secretary for Planning and Evaluation (ASPE) are undertaking to develop a
Letter to Congressional leaders from organizations to voice strong support for the Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act (S. 974/H.R.